David Zaccardelli's Net Worth
David Zaccardelli's net worth is estimated to be at least $18,260,418.88 as of 12/22/2024. CoreStreet's estimation of David Zaccardelli's net worth is based on their sale of stock and current holding of stock.
David Zaccardelli is CEO at Verona Pharma PLC ADR. They have executed at least 40 trades of stock as per SEC Form 4 filings. Their most recent trade was for 162,800 units of VRNA stock on 12/06/2024. Their biggest sale was on 12/20/2022 when they sold 600,000 units of Verona Pharma PLC ADR stock for $1,272,000.00. They typically trade 8 times per year.
Total value of insider buys:
- $0.00
Total value of insider sells:
- $18,260,418.88
Most recent insider trade:
- Dec. 6, 2024
David Zaccardelli's Insider Trading History
| Verona Pharma PLC ADR | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 6, 2024 | CEO | 162,800 | $5.01 | Sell | $815,628.00 |
Dec. 4, 2024 | CEO | 67,608 | $5.00 | Sell | $338,040.00 |
Dec. 2, 2024 | CEO | 3,200 | $5.00 | Sell | $16,000.00 |
Nov. 29, 2024 | CEO | 98,888 | $5.01 | Sell | $495,428.88 |
Nov. 27, 2024 | CEO | 23,240 | $5.00 | Sell | $116,200.00 |
Nov. 11, 2024 | CEO | 2,400 | $5.00 | Sell | $12,000.00 |
Nov. 4, 2024 | CEO | 94,144 | $4.39 | Sell | $413,292.16 |
Nov. 1, 2024 | CEO | 46,888 | $4.38 | Sell | $205,369.44 |
Oct. 25, 2024 | CEO | 4,800 | $4.38 | Sell | $21,024.00 |
Oct. 23, 2024 | CEO | 16 | $4.38 | Sell | $70.08 |
Oct. 21, 2024 | CEO | 110,456 | $4.38 | Sell | $483,797.28 |
Oct. 18, 2024 | CEO | 245,784 | $4.38 | Sell | $1,076,533.92 |
Aug. 7, 2023 | CEO | 8,616 | $2.47 | Sell | $21,281.52 |
Aug. 4, 2023 | CEO | 150,000 | $2.50 | Sell | $375,000.00 |
Aug. 2, 2023 | CEO | 73,704 | $2.59 | Sell | $190,893.36 |
May 1, 2023 | CEO | 455,536 | $2.58 | Sell | $1,175,282.88 |
Feb. 1, 2023 | CEO | 432,928 | $2.56 | Sell | $1,108,295.68 |
Dec. 20, 2022 | CEO | 600,000 | $2.12 | Sell | $1,272,000.00 |
Aug. 9, 2022 | CEO | 600,000 | $1.75 | Sell | $1,050,000.00 |
Aug. 1, 2022 | CEO | 32,904 | $0.70 | Sell | $23,032.80 |
May 3, 2022 | CEO | 32,904 | $0.50 | Sell | $16,452.00 |
Feb. 3, 2022 | CEO | 52,056 | $0.73 | Sell | $38,000.88 |
Nov. 2, 2021 | CEO | 52,056 | $0.64 | Sell | $33,315.84 |
Aug. 3, 2021 | CEO | 16,000 | $0.76 | Sell | $12,160.00 |
March 1, 2021 | CEO | 43,392 | $1.14 | Sell | $49,466.88 |
| United Therapeutics Corporation | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
April 14, 2015 | COO | 3,250 | $185.82 | Sell | $603,915.00 |
April 9, 2015 | COO | 4,000 | $184.84 | Sell | $739,360.00 |
April 7, 2015 | COO | 4,000 | $179.34 | Sell | $717,360.00 |
April 2, 2015 | COO | 4,000 | $174.73 | Sell | $698,920.00 |
March 26, 2015 | COO | 4,000 | $167.52 | Sell | $670,080.00 |
March 24, 2015 | COO | 4,500 | $179.51 | Sell | $807,795.00 |
March 17, 2015 | COO | 4,000 | $177.34 | Sell | $709,360.00 |
Feb. 24, 2015 | COO | 1,458 | $155.16 | Sell | $226,223.28 |
Feb. 17, 2015 | COO | 4,000 | $155.14 | Sell | $620,560.00 |
Feb. 10, 2015 | COO | 4,000 | $146.68 | Sell | $586,720.00 |
Feb. 3, 2015 | COO | 4,000 | $141.99 | Sell | $567,960.00 |
Jan. 27, 2015 | COO | 4,000 | $147.19 | Sell | $588,760.00 |
Jan. 20, 2015 | COO | 4,000 | $146.48 | Sell | $585,920.00 |
Jan. 13, 2015 | COO | 3,000 | $134.71 | Sell | $404,130.00 |
Jan. 6, 2015 | COO | 3,000 | $124.93 | Sell | $374,790.00 |